Low free and bioavailable testosterone levels may predict pathologicallyproven high-risk prostate cancer: a prospective, clinical trial
Göksel Bayar, Hakan Şirin, Mustafa Aydın, Ayşim Özağarı, Orhan Tanrıverdi, Mustafa Kadıhasanoğlu, Muammer Kendirci
(Urol Res Pract 2017; 43: 289-296) DOI: 10.5152/tud.2017.35467